Bupropion with Propranolol: Safety and Clinical Recommendations
Combining bupropion with propranolol is generally safe but requires careful monitoring due to a clinically significant drug interaction—bupropion inhibits CYP2D6, which can increase propranolol levels by 4-6 fold, potentially causing bradycardia, hypotension, and heart block.
Mechanism of Drug Interaction
Bupropion is a potent CYP2D6 inhibitor 1, and propranolol is primarily metabolized by this enzyme 2. When combined, bupropion significantly increases propranolol plasma concentrations, similar to the interaction seen with other potent CYP2D6 inhibitors like fluoxetine and paroxetine 3. This metabolic interaction can lead to excessive beta-blockade with serious hemodynamic consequences 2.
Clinical Evidence of Risk
A large survival analysis of 21,292 patients in the California Medicaid system demonstrated that patients receiving bupropion with beta-blockers had a 53% increased risk of hospitalization or emergency department visits for hemodynamic events within 30 days (HR 1.53,95% CI 1.03-2.81; p=0.04) 2. The study specifically identified bupropion as one of the antidepressants with moderate to strong CYP2D6 inhibitory potential that posed this elevated risk 2.
Case reports have documented severe bradycardia and atrioventricular block in patients taking propranolol combined with potent CYP2D6 inhibitors including bupropion 3. One case series noted that the most common adverse effect (37.9% of cases) was bradycardia when combining beta-blockers with bupropion or SSRIs 4.
Recommended Management Strategy
If Combination is Necessary:
1. Reduce propranolol dose by 50-75% when initiating bupropion to account for the expected 4-6 fold increase in bioavailability 3.
2. Monitor vital signs closely:
- Measure heart rate and blood pressure before starting bupropion
- Recheck at 1 week, 2 weeks, and 4 weeks after initiation
- Watch for heart rate <60 bpm or systolic BP <90 mmHg 2
3. Educate patients to report immediately:
- Dizziness, lightheadedness, or syncope
- Unusual fatigue or weakness
- Shortness of breath
- Any falls 2
4. Higher risk patients require more intensive monitoring:
- Advanced age
- Male sex
- African American or Hispanic ethnicity
- Already on higher beta-blocker doses 2
Safer Alternatives to Consider:
If the antidepressant can be changed: Consider switching to antidepressants with minimal CYP2D6 inhibition such as sertraline, venlafaxine, mirtazapine, or mianserin, which do not cause clinically relevant interactions with propranolol 3.
If the beta-blocker can be changed: Consider switching to beta-blockers that are not primarily CYP2D6 substrates, such as atenolol or bisoprolol, which are renally eliminated and would not be affected by bupropion 5.
Starting Doses When Combination is Required
- Propranolol: Start at 10-20 mg twice daily (50-75% reduction from standard starting dose of 40 mg twice daily) 5
- Bupropion: Use standard dosing: 150 mg once daily for 3 days, then 150 mg twice daily 1
Common Pitfalls to Avoid
- Do not assume standard beta-blocker dosing is safe when adding bupropion—dose reduction is mandatory
- Do not rely solely on patient symptoms—many patients with bradycardia are asymptomatic until severe
- Do not forget to reassess if either medication is discontinued—propranolol dose may need to be increased back to therapeutic levels if bupropion is stopped
- Do not combine with other CYP2D6 inhibitors simultaneously (e.g., adding an SSRI to this combination) 1
Contraindications to This Combination
The combination should be avoided entirely in patients with: